Literature DB >> 34204571

The Role of Oxidative Stress in NAFLD-NASH-HCC Transition-Focus on NADPH Oxidases.

Daniela Gabbia1, Luana Cannella1, Sara De Martin1.   

Abstract

A peculiar role for oxidative stress in non-alcoholic fatty liver disease (NAFLD) and its transition to the inflammatory complication non-alcoholic steatohepatitis (NASH), as well as in its threatening evolution to hepatocellular carcinoma (HCC), is supported by numerous experimental and clinical studies. NADPH oxidases (NOXs) are enzymes producing reactive oxygen species (ROS), whose abundance in liver cells is closely related to inflammation and immune responses. Here, we reviewed recent findings regarding this topic, focusing on the role of NOXs in the different stages of fatty liver disease and describing the current knowledge about their mechanisms of action. We conclude that, although there is a consensus that NOX-produced ROS are toxic in non-neoplastic conditions due to their role in the inflammatory vicious cycle sustaining the transition of NAFLD to NASH, their effect is controversial in the neoplastic transition towards HCC. In this regard, there are indications of a differential effect of NOX isoforms, since NOX1 and NOX2 play a detrimental role, whereas increased NOX4 expression appears to be correlated with better HCC prognosis in some studies. Further studies are needed to fully unravel the mechanisms of action of NOXs and their relationships with the signaling pathways modulating steatosis and liver cancer development.

Entities:  

Keywords:  NADPH oxidases; NAFLD; NASH; NOX; hepatocellular carcinoma HCC; oxidative stress

Year:  2021        PMID: 34204571     DOI: 10.3390/biomedicines9060687

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  12 in total

Review 1.  NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook.

Authors:  Alberto Nascè; Karim Gariani; François R Jornayvaz; Ildiko Szanto
Journal:  Antioxidants (Basel)       Date:  2022-06-09

Review 2.  A Molecular Insight into the Role of Antioxidants in Nonalcoholic Fatty Liver Diseases.

Authors:  Devaraj Ezhilarasan; Thangavelu Lakshmi
Journal:  Oxid Med Cell Longev       Date:  2022-05-11       Impact factor: 7.310

3.  The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLD.

Authors:  Daniela Gabbia; Marco Roverso; Samantha Sarcognato; Ilaria Zanotto; Nicola Ferri; Francesco Paolo Russo; Maria Guido; Sara Bogialli; Sara De Martin
Journal:  Biology (Basel)       Date:  2022-04-30

Review 4.  The Nuclear Receptor PXR in Chronic Liver Disease.

Authors:  Katia Sayaf; Ilaria Zanotto; Francesco Paolo Russo; Daniela Gabbia; Sara De Martin
Journal:  Cells       Date:  2021-12-27       Impact factor: 6.600

5.  Study on Syndrome Intervention of Nonalcoholic Fatty Liver Disease from the Perspective of Deficiency and Excess.

Authors:  Sanhang Wang; Hu Jiu Lüe; Jiao Zhao
Journal:  J Healthc Eng       Date:  2021-09-15       Impact factor: 2.682

6.  Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1/AMPK/NRF2 Signaling.

Authors:  Yunyi Zou; Zhanglin Chen; Chenchen Sun; Dong Yang; Zuoqiong Zhou; Xiyang Peng; Lan Zheng; Changfa Tang
Journal:  Int J Mol Sci       Date:  2021-10-10       Impact factor: 5.923

7.  Ganoderic acid A ameliorates non-alcoholic streatohepatitis (NASH) induced by high-fat high-cholesterol diet in mice.

Authors:  Jing Zhu; Jiexia Ding; Siying Li; Jie Jin
Journal:  Exp Ther Med       Date:  2022-02-24       Impact factor: 2.447

8.  A maternal high-fat diet induces fetal origins of NASH-HCC in mice.

Authors:  Takao Takiyama; Toshihiro Sera; Masanori Nakamura; Masato Hoshino; Kentaro Uesugi; Shin-Ichi Horike; Makiko Meguro-Horike; Ryoichi Bessho; Yuri Takiyama; Hiroya Kitsunai; Yasutaka Takeda; Kazuki Sawamoto; Naoto Yagi; Yuji Nishikawa; Yumi Takiyama
Journal:  Sci Rep       Date:  2022-07-30       Impact factor: 4.996

Review 9.  Update on the Pharmacological Treatment of Primary Biliary Cholangitis.

Authors:  Annarosa Floreani; Daniela Gabbia; Sara De Martin
Journal:  Biomedicines       Date:  2022-08-20

Review 10.  Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease.

Authors:  Yuanqiang Ma; Gyurim Lee; Su-Young Heo; Yoon-Seok Roh
Journal:  Antioxidants (Basel)       Date:  2021-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.